US Stock MarketDetailed Quotes
LLY Eli Lilly and Co
- 884.140
- +18.170+2.10%
Trading Jul 23 12:25 ET
840.29BMarket Cap130.21P/E (TTM)
887.720High864.080Low979.61KVolume870.900Open865.970Pre Close861.20MTurnover0.10%Turnover Ratio152.44P/E (Static)950.41MShares966.10052wk High65.58P/B838.36BFloat Cap443.57052wk Low4.69Dividend TTM948.22MShs Float966.100Historical High0.53%Div YieldTTM2.73%Amplitude5.294Historical Low879.132Avg Price1Lot Size
About Eli Lilly and Co Company
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.
Company Profile
SymbolLLY
Company NameEli Lilly and Co
Listing DateApr 1, 1973
Founded1876
CEOMr. David A. Ricks
MarketNYSE
Employees43000
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
AddressLilly Corporate Center
CityIndianapolis
ProvinceIndiana
CountryUnited States of America
Zip Code46285
Phone1-317-276-2000
Websitehttp://www.lilly.com
Company Executives
- Name
- Position
- Salary
- David A. Ricks
- Chairman of the Board, President and Chief Executive Officer
- 26.57M
- Dr. Daniel M. Skovronsky, M.D.
- Executive Vice President, Chief Scientific Officer and President, Lilly Research Laboratories and Lilly Immunology
- 11.85M
- Gordon J. Brooks
- Interim Chief Financial Officer
- --
- Diogo Rau
- Executive Vice President, Chief Information Officer and Chief Digital Officer
- --
- Donald A. Zakrowski
- Senior Vice President, Finance and Chief Accounting Officer
- --
- Alonzo Weems
- Executive Vice President, Enterprise Risk Management, Chief Ethics Officer and Compliance Officer
- --
- Edgardo Hernandez
- Executive Vice President and President, Manufacturing Operations
- --
- Patrik Jonsson
- Executive Vice President and President, Lilly Diabetes and Obesity; President, Lilly USA
- --
- Anne E. White
- Executive Vice President and President, Lilly Neuroscience
- --
- Jacob S. Van Naarden
- Executive Vice President and President, Loxo
- 4.89M
- Ilya Yuffa
- Executive Vice President and President, Lilly International
- --
- Eric Dozier
- Executive Vice President, Human Resources and Diversity
- --
- Anat Hakim
- Executive Vice President, General Counsel and Secretary
- 7.01M
- Johna L. Norton
- Executive Vice President, Global Quality
- --
- Jon Erik Fyrwald
- Independent Director
- 344.88K
- Kimberly H. Johnson
- Independent Director
- 316.00K
- Katherine Baicker
- Independent Director
- 336.00K
- Ralph Alvarez
- Independent Director
- 336.00K
- Juan R. Luciano
- Lead Independent Director
- 373.00K
- Gabrielle Sulzberger, J.D.,M.B.A.
- Independent Director
- 335.50K
- Marschall S. Runge
- Independent Director
- 319.00K
- Dr. Mary Lynne Hedley,PhD
- Independent Director
- 319.00K
- Karen Walker
- Independent Director
- 359.00K
- Jamere Jackson
- Independent Director
- 345.00K
- Dr. William G. Kaelin, Jr
- Independent Director
- 349.15K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
